JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: LY3214996 is a novel, highly potent, selective and orally bioavailable inhibitor of the ERK1 (extracellular signal-regulated kinase) and ERK2, with IC50 value of 5 nM for both enzymes (ERK1/2) in biochemical assays. LY3214996 inhibits both ERK 1 and 2, thereby preventing the activation of the MAPK (mitogen-activated protein kinase)/ERK-mediated signal pathways. This results in the inhibition of ERK-dependent tumor cell proliferation and survival. It potently inhibits cellular phospho-RSK1 in BRAF and RAS mutant cancer cell lines. Therefore, LY-3214996 has the potential to be developed as an antineoplastic drug. LY3214996 also significantly inhibited the growth and migration of the AGO1 cells.
References: Cancer Research 77(13 Supplement):3231-3231; Cell Death Dis. 2018 Feb 27; 9(3):324.
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!